Olga A. Sharshova

Olga A. Sharshova

Auto-generated profile, based on publicly available information

Olga A. Sharshova

S.M. Kirov Military Medical Academy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2026 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Closed access
IZI. S. Zakharov
I. S. Zakharov
ANA. A. Nazarenko
A. A. Nazarenko
ABA. A. Bezmenko
A. A. Bezmenko
OSO. A. Sharshova
O. A. Sharshova
In 2025, it will be 120 years since the first successful full-fledged telemedicine communication. This article describes the main stages of telemedicine development. The first attempts to provide remote medical care are inextricably linked with the invention of the telegraph. Throughout the 20th century and the first quarter of the 21st century, telemedicine technologies have been progressively developing. The authors analyzed the general chronological dynamics of the distribution of scientific publications on telemedicine — a significant increase in publication activity occurred during the COVID-19 pandemic, which became an important stage in the development and transformation of this area of medical services. Using cluster analysis, a classification of areas in which telemedicine is actively used was carried out. Promising areas were identified, one of which is the combination of telemedicine with artificial intelligence. The active development of telemedicine is changing approaches to medical care and forming a new understanding of the relationship «doctor–patient», «doctor–doctor» and «patient–patient».

1 January 2026 in Obstetrics and gynecology: News, Opinions, Training
Verified
Journal Article
Closed access
IZI.S. Zakharov
I.S. Zakharov
MKM.G. Karailanov
M.G. Karailanov
ABA.A. Bezmenko
A.A. Bezmenko
ANA.A. Nazarenko
A.A. Nazarenko
OSO.A. Sharshova
O.A. Sharshova
ASA.R. Sharshov
A.R. Sharshov

30 April 2026 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Closed access
PDF file
IZIgor S. Zakharov
Igor S. Zakharov
MKMikhail G. Karailanov
Mikhail G. Karailanov
ANAlina A. Nazarenko
Alina A. Nazarenko
ABAleksandr A. Bezmenko
Aleksandr A. Bezmenko
OSOlga A. Sharshova
Olga A. Sharshova
TMTatiana V. Mironova
Tatiana V. Mironova
Introduction: Despite the active adoption of digital innovations in healthcare delivery, the acceptance of artificial intelligence in the medical community remains unclear. Objective: To establish AI acceptance in colposcopy by surveying obstetricians and gynecologists. Materials and Methods: We conducted a cross-sectional anonymous survey of 392 obstetricians and gynecologists in St. Petersburg and the Leningrad Region. The developed questionnaire included three sets of questions: the first set characterized the respondent’s profile; the second set comprised questions related to the Unified Theory of Acceptance and Use of Technology; and the third set of additional questions addressed the risks of adopting new technologies, including ethical and legal aspects. Results and Discussion: We observed positive trends in obstetricians and gynecologists’ intentions to use artificial intelligence in their practice. At the same time, the analysis revealed a number of problems, including insufficient trust in AI-generated results, limited availability of equipment and technical support. Another issue of concern for healthcare professionals is the partial substitution of their functions. Furthermore, the majority of respondents (247 (63 %)) believe that the existing legal framework is insufficient for the safe practical AI use. Moreover, many respondents (292 (74.5 %)) believe that legal liability for artificial intelligence errors should lie with the healthcare facility and the software developer, while only one in five respondents (80 (20.4 %)) believes that liability should be shared. Conclusions: This study is the first to provide a comprehensive assessment of the readiness of obstetricians and gynecologists to use artificial intelligence tools in colposcopy in the Russian Federation. It should be assumed that the level of hypothetical support for the adoption of innovations may be quite high but practical implementation is limited by infrastructural barriers and legal uncertainty.

1 January 2025 in Bulletin of Medical Science
Verified
Journal Article
Open access
SASaint Petersburg Military Medical Academy
Saint Petersburg Military Medical Academy
IZIgor S. Zakharov
Igor S. Zakharov
OSOlga A. Sharshova
Olga A. Sharshova
ABAlexander A. Bezmenko
Alexander A. Bezmenko
VMVeronika I. Malyugina
Veronika I. Malyugina
APAnna V. Popova
Anna V. Popova
The article presents an analysis of scientific studies investigating the effect of autoimmune diseases (AIDs) on the risk of developing cervical intraepithelial lesions, including cervical cancer. 458 scientific publications in foreign and domestic search engines PubMed, Cochrane, and Elibrary were analyzed by keywords and their combinations: "cervical cancer", "autoimmune diseases", "immunosuppressive therapy", "cervical intraepithelial neoplasia", "risk of developing cervical cancer". The final review included 28 articles. The qualitative analysis allowed us to form an idea of the effect of AIDs on the development of intraepithelial neoplastic changes in cervical cancer (CC), in the pathogenesis of which an important place is occupied by the chronic inflammatory process – there is activation of signaling pathways, including NF-kB, JAK-STAT, MAPK and TLR. These agents induce the production of various proinflammatory, tissue-damaging factors, such as cytokines, chemokines, and metalloproteinases. In addition, both in AID and in CC, activated inflammasomes and the signaling pathway of the GMP-AMP interferon synthase stimulating gene (cGAS-STING) are involved in the development of chronic inflammation. It is noted that the C5aR system is associated with carcinogenesis activity and the recruitment of myeloid suppressor cells MDSC, which suppress the antitumor immune response. The presence of immunosuppressive therapy (mainly the use of azathioprine) plays an important role in the progression of intraepithelial changes in the cervix. Several studies present data on the positive effect of vaccination against human papillomavirus (HPV) in patients with systemic lupus erythematosus, while it is recommended to vaccinate against HPV regardless of the presence or absence of this virus in anamnesis. Along with the literature review, the article presents a clinical case of intraepithelial cervical lesion in a patient with systemic lupus erythematosus. Therefore, immunological changes in AIDs in combination with immunosuppressive therapy can contribute to the progression of carcinogenesis. At the same time, it should be noted that when studying this topic, controversial issues remain, which require further development of this problem.